AUGX NASDAQ
Augmedix, Inc.
1W: +0.4%
1M: +1.7%
3M: +135.0%
1Y: -55.3%
3Y: -55.2%
$2.35
Last traded 2024-10-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$45M
+45.0% ▲
5Y CAGR: +32.9%
Gross Profit
$22M
+54.3% ▲
5Y CAGR: +93.9%
Operating Income
-$19M
+16.1% ▲
Net Income
-$19M
+27.7% ▲
EPS (Diluted)
$-0.44
+38.0% ▲
EBITDA
-$16M
+18.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $14M | $16M | $22M | $31M | $45M |
| YoY Growth | +30.4% | +16.8% | +34.5% | +39.6% | +45.0% |
| Cost of Revenue | $9M | $10M | $12M | $17M | $23M |
| Gross Profit | $5M | $7M | $10M | $14M | $22M |
| Gross Margin | 33.2% | 41.2% | 45.1% | 45.1% | 48.0% |
| R&D Expenses | $7M | $5M | $7M | $10M | $11M |
| SG&A Expenses | $14M | $16M | $21M | $26M | $29M |
| Operating Expenses | $21M | $20M | $28M | $36M | $40M |
| Operating Income | -$17M | -$14M | -$18M | -$22M | -$19M |
| Operating Margin | -118.7% | -83.1% | -80.9% | -72.3% | -41.9% |
| Interest Expense | $3M | $1M | $2M | $2M | $2M |
| Income Before Tax | -$18M | -$16M | -$18M | -$24M | -$19M |
| Tax Expense | $0 | $0 | -$691K | $0 | $145K |
| Net Income | -$22M | -$15M | -$17M | -$27M | -$19M |
| Net Margin | -158.5% | -89.4% | -77.4% | -85.8% | -42.7% |
| EPS (Diluted) | $-26.89 | $-0.55 | $-0.59 | $-0.71 | $-0.44 |
| EBITDA | -$15M | -$13M | -$14M | -$22M | -$16M |
| Shares Outstanding | 831590 | 27M | 29M | 37M | 44M |